{"nct_id":"NCT01777334","title":"The Purpose of This Study is to Evaluate the Spirometric Effect (Trough FEV1) of Umeclidinium/Vilanterol 62.5/25 mcg Once Daily Compared With Tiotriopium 18 mcg Once Daily Over a 24-week Treatment Period in Subjects With COPD","status":"COMPLETED","status_verified_date":"2018-01","start_date":"2013-01-23","start_date_type":"ACTUAL","primary_completion_date":"2013-09-24","primary_completion_date_type":"ACTUAL","completion_date":"2013-09-24","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["GSK"]}